Top View
- New Perspectives on Polycythemia Vera: from Diagnosis to Therapy
- Histone Deacetylase Inhibitors for Purging HIV-1 from the Latent Reservoir
- Inhibition of Histone Deacetylases in Inflammatory Bowel Diseases
- Assessment Report
- Histone Deacetylase Inhibitors for CTCL
- High-Throughput Identification of Post-Transcriptional Utrophin Up
- A View Into Upcoming Specialty & Traditional Drugs
- HDAC Inhibitors Promote Intestinal Epithelial Regeneration Via Autocrine Tgfβ1 Signalling in Inflammation
- Chemical Synthesis of New Histone Deacetylase Inhibitors and Their Evaluation As Anticancer Agents
- COMP Agenda 1-3 September 2015
- ITF2357) on Human Glioblastoma Cancer Stem Cells
- (2006.01) Ao, At, Au, Az, Ba, Bb, Bg, Bh, Bn, Br, Bw, By, Bz, 10
- PCORI Health Care Horizon Scanning Status Report
- Histone Deacetylase Inhibitors As Potential COVID-19 Virus RNA-Dependent RNA Polymerase Inhibitors: a Molecular Docking and Dynamics Study
- Autophagy Induction by Histone Deacetylase
- Inhibition of Class I Histone Deacetylases 1 and 2 Promotes Urothelial Carcinoma Cell Death by Various Mechanisms Maria Pinkerneil1, Michele J
- Non-Coding DNA in IBD: from Sequence Variation in Gut: First Published As 10.1136/Gutjnl-2018-317516 on 28 January 2019
- Comparison of HDAC Inhibitors in Clinical Development Effect on HIV Production in Latently Infected Cells and T-Cell Activation